ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 145 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $28,202,000 | +21.6% | 5,009,362 | +18.6% | 26.68% | +19.9% |
| Q2 2016 | $23,184,000 | -0.9% | 4,223,040 | +33.9% | 22.26% | -6.5% |
| Q1 2016 | $23,396,000 | +17.4% | 3,153,040 | +31.5% | 23.80% | -7.8% |
| Q4 2015 | $19,927,000 | +24.2% | 2,398,040 | +34.6% | 25.82% | -5.2% |
| Q3 2015 | $16,047,000 | -20.5% | 1,781,040 | +5.8% | 27.24% | +21.7% |
| Q2 2015 | $20,197,000 | +46.1% | 1,683,064 | +31.2% | 22.39% | +59.3% |
| Q1 2015 | $13,821,000 | +52.6% | 1,283,204 | -28.2% | 14.06% | +57.1% |
| Q4 2014 | $9,059,000 | +209.5% | 1,786,700 | +61.2% | 8.94% | +289.9% |
| Q3 2014 | $2,927,000 | -61.7% | 1,108,700 | -41.5% | 2.29% | -58.4% |
| Q2 2014 | $7,642,000 | -26.5% | 1,896,222 | -16.5% | 5.51% | -36.9% |
| Q1 2014 | $10,396,000 | -6.6% | 2,269,925 | -11.5% | 8.74% | -2.8% |
| Q4 2013 | $11,132,000 | – | 2,564,925 | – | 8.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |